v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 35,459 $ 35,461
Restricted cash 5,550 5,550
Accounts receivable, net of allowance for credit losses of $661 and $723, respectively 19,857 22,931
Inventory 18,194 15,291
Prepaid expenses and other current assets 3,392 2,684
Total current assets 82,452 81,917
Property and equipment, net 720 295
Intangible assets, net 1,748 1,391
Other assets 1,837 2,028
Total assets 86,757 85,631
Current liabilities:    
Accounts payable 11,781 11,967
Accrued and other expenses 17,135 19,427
Current portion of deferred revenue 2,409 2,282
Line of credit 13,353 6,932
Current portion of long-term and other debt 3,465 3,635
Total current liabilities 48,143 44,243
Long-term debt, net 1,950 2,463
Common stock warrant liabilities 648 3,273
Other long-term liabilities 170 197
Total liabilities 50,911 50,176
Commitments and Contingencies
Mezzanine equity:    
Mezzanine equity 14,835 16,413
Stockholders’ equity:    
Common stock, $0.0001 par value, 107,142,857 shares authorized as of March 31, 2026 and December 31, 2025; 28,099,112 and 26,945,426 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 3 3
Additional paid-in capital 332,217 326,912
Accumulated deficit (311,209) (307,873)
Total stockholders’ equity 21,011 19,042
Total liabilities, mezzanine equity, and stockholders' equity 86,757 85,631
Series A Convertible Preferred Stock    
Mezzanine equity:    
Mezzanine equity 7,651 7,151
Series B Convertible Preferred Stock    
Mezzanine equity:    
Mezzanine equity 5,192 4,844
Redeemable Common Stock    
Mezzanine equity:    
Mezzanine equity $ 1,992 $ 4,418